Skip to main content

Advertisement

Table 1 Clinical and laboratory characteristics of patients with gouty arthritis and healthy controls

From: MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis

  Healthy controls Patient
Total number 10 14
Age, mean (range) years* 51 (25 to 65) 55 (31 to 68)
Male, number (%)* 10 (100) 14 (100)
Duration of acute gout, mean (range) days NA 2 (1 to 4)
Co-morbidity NA  
  Diabetes, number (%)   3 (21.4)
  Hypertension, number (%)   4 (28.5)
  Hypercholesterolemia, number (%)   1 (7.1)
  Cardiovascular disease, number (%)   2 (14.3)
Current medicines NA  
  Naive, number (%)   14 (100)
Location of arthritis NA  
  First MTP joint, number (%)   10 (71.4)
  Knee joint, number (%)   12 (72.3)
  Ankle joint, number (%)   2 (14.3)
Serum urate level, mean (range) mg/dl NA 7 (5 to 12)
ESR, mean (range, mm/h) NA 55 (45 to 61)
CRP, mean (range, mg/dL) NA 12.5 (5.8 to 18.3)
  1. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MTP, metatarsophalangeal; NA, not applicable. *Not significant.